Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Ganswindt

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Der Urologe. Ausg. A|July 22, 2008
[Radiotherapy in prostate cancer]U Ganswindt, C Belka
Der Urologe. Ausg. A|September 29, 2006
[Recurrence of prostate cancer--value of salvage radiotherapy]C Belka, U Ganswindt
Der Urologe. Ausg. A|February 14, 2016
[Localized intermediate- to high-risk prostate cancer]S Tritschler, U Ganswindt, C G Stief
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 19, 2014
Primary non-small cell lung cancer in a transplanted lung treated with stereotactic body radiation therapy. A case studyF Oskan, U Ganswindt, C Belka, et al.
Physics in Medicine and Biology|December 31, 2014
Intra-fraction motion of the prostate is a random walkH Ballhausen, M Li, N-S Hegemann, et al.
Radiation Oncology (London, England)|May 26, 2006
Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I studyU Ganswindt, W Budach, V Jendrossek, et al.
Der Urologe. Ausg. A|October 7, 2017
[Radiation therapy of locally advanced prostate cancer]N-S Schmidt-Hegemann, M Li, C Eze, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 24, 2014
Hippocampus sparing in whole-brain radiotherapy. A reviewF Oskan, U Ganswindt, S B Schwarz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2012
Radiation treatment parameters for re-irradiation of malignant gliomaM Niyazi, M Söhn, S B Schwarz, et al.
Journal of Cancer Research and Clinical Oncology|May 12, 2005
70 Gy or more: which dose for which prostate cancer?U Ganswindt, F Paulsen, A G Anastasiadis, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Der Urologe. Ausg. A|July 22, 2008
[Radiotherapy in prostate cancer]U Ganswindt, C Belka
Der Urologe. Ausg. A|September 29, 2006
[Recurrence of prostate cancer--value of salvage radiotherapy]C Belka, U Ganswindt
Der Urologe. Ausg. A|February 14, 2016
[Localized intermediate- to high-risk prostate cancer]S Tritschler, U Ganswindt, C G Stief
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 19, 2014
Primary non-small cell lung cancer in a transplanted lung treated with stereotactic body radiation therapy. A case studyF Oskan, U Ganswindt, C Belka, et al.
Physics in Medicine and Biology|December 31, 2014
Intra-fraction motion of the prostate is a random walkH Ballhausen, M Li, N-S Hegemann, et al.
Radiation Oncology (London, England)|May 26, 2006
Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I studyU Ganswindt, W Budach, V Jendrossek, et al.
Der Urologe. Ausg. A|October 7, 2017
[Radiation therapy of locally advanced prostate cancer]N-S Schmidt-Hegemann, M Li, C Eze, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 24, 2014
Hippocampus sparing in whole-brain radiotherapy. A reviewF Oskan, U Ganswindt, S B Schwarz, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 22, 2012
Radiation treatment parameters for re-irradiation of malignant gliomaM Niyazi, M Söhn, S B Schwarz, et al.
Journal of Cancer Research and Clinical Oncology|May 12, 2005
70 Gy or more: which dose for which prostate cancer?U Ganswindt, F Paulsen, A G Anastasiadis, et al.
Pageof 3